Sean Laaman
Stock Analyst at Morgan Stanley
(4.82)
# 475
Out of 4,581 analysts
556
Total ratings
67.8%
Success rate
15.8%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MPLT MapLight Therapeutics | Downgraded: Hold | $34 → $21 | $12.31 | +70.59% | 6 | Jul 28, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,180 → $1,200 | $872.23 | +37.58% | 11 | Jul 24, 2026 | |
| EXEL Exelixis | Rated: Hold | $50 → $53 | $56.51 | -6.21% | 19 | Jul 23, 2026 | |
| NBIX Neurocrine Biosciences | Rated: Hold | $191 → $193 | $182.83 | +5.56% | 18 | Jul 23, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $395 | $330.46 | +19.53% | 11 | Jul 23, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 → $36 | $24.05 | +49.69% | 9 | Jul 23, 2026 | |
| ERAS Erasca | Maintained: Hold | $12 → $21 | $18.16 | +15.64% | 7 | Jul 20, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Hold | $26 | $26.01 | -0.04% | 11 | Jun 26, 2026 | |
| ABSI Absci | Rated: Hold | $4.1 → $10 | $7.13 | +40.25% | 8 | Jun 25, 2026 | |
| IRON Disc Medicine | Rated: Buy | $80 → $85 | $74.65 | +13.86% | 12 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $83.45 | +11.45% | 18 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $17.47 | +71.72% | 9 | Jun 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $98 | $85.55 | +14.55% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $72.62 | +28.06% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.59 | +109.55% | 4 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $15.29 | +11.18% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $5.5 | $3.05 | +80.33% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $14.16 | +12.99% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $22 | $13.14 | +67.43% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $120 → $119 | $62.07 | +91.72% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $226 → $245 | $256.92 | -4.64% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $217 → $242 | $234.20 | +3.33% | 9 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.9 → $2 | $1.52 | +31.58% | 5 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $9.49 | +237.20% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $33.51 | +19.37% | 4 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.98 | +10.74% | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $7.91 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.80 → $3.95 | $5.24 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $208.96 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.70 | $29.99 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310.00 | $128.07 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.60 → $31.65 | $22.72 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.38 → $24.14 | $33.64 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.85 → $27.79 | $41.75 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $276.00 → $256.00 | $122.50 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.30 | $0.38 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.15 → $7.35 | $7.66 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.45 → $1.65 | $0.69 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.90 → $45.69 | $22.61 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53.60 → $51.60 | $44.26 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.70 → $2.75 | $2.09 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.45 | n/a | 2 | Aug 24, 2021 |
MapLight Therapeutics
Jul 28, 2026
Downgraded: Hold
Price Target: $34 → $21
Current: $12.31
Upside: +70.59%
argenx SE
Jul 24, 2026
Rated: Buy
Price Target: $1,180 → $1,200
Current: $872.23
Upside: +37.58%
Exelixis
Jul 23, 2026
Rated: Hold
Price Target: $50 → $53
Current: $56.51
Upside: -6.21%
Neurocrine Biosciences
Jul 23, 2026
Rated: Hold
Price Target: $191 → $193
Current: $182.83
Upside: +5.56%
BeOne Medicines AG
Jul 23, 2026
Maintained: Buy
Price Target: $395
Current: $330.46
Upside: +19.53%
Denali Therapeutics
Jul 23, 2026
Maintained: Buy
Price Target: $35 → $36
Current: $24.05
Upside: +49.69%
Erasca
Jul 20, 2026
Maintained: Hold
Price Target: $12 → $21
Current: $18.16
Upside: +15.64%
ACADIA Pharmaceuticals
Jun 26, 2026
Maintained: Hold
Price Target: $26
Current: $26.01
Upside: -0.04%
Absci
Jun 25, 2026
Rated: Hold
Price Target: $4.1 → $10
Current: $7.13
Upside: +40.25%
Disc Medicine
Jun 16, 2026
Rated: Buy
Price Target: $80 → $85
Current: $74.65
Upside: +13.86%
Jun 15, 2026
Maintained: Buy
Price Target: $93
Current: $83.45
Upside: +11.45%
Jun 7, 2026
Maintained: Buy
Price Target: $30
Current: $17.47
Upside: +71.72%
May 27, 2026
Maintained: Buy
Price Target: $94 → $98
Current: $85.55
Upside: +14.55%
May 15, 2026
Maintained: Buy
Price Target: $93
Current: $72.62
Upside: +28.06%
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $8.59
Upside: +109.55%
May 14, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $15.29
Upside: +11.18%
May 14, 2026
Maintained: Hold
Price Target: $5 → $5.5
Current: $3.05
Upside: +80.33%
May 14, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $14.16
Upside: +12.99%
May 14, 2026
Maintained: Buy
Price Target: $20 → $22
Current: $13.14
Upside: +67.43%
May 6, 2026
Rated: Buy
Price Target: $120 → $119
Current: $62.07
Upside: +91.72%
May 5, 2026
Maintained: Buy
Price Target: $226 → $245
Current: $256.92
Upside: -4.64%
May 5, 2026
Rated: Hold
Price Target: $217 → $242
Current: $234.20
Upside: +3.33%
May 4, 2026
Maintained: Sell
Price Target: $0.9 → $2
Current: $1.52
Upside: +31.58%
Mar 3, 2026
Maintained: Buy
Price Target: $32
Current: $9.49
Upside: +237.20%
Feb 26, 2026
Maintained: Hold
Price Target: $40
Current: $33.51
Upside: +19.37%
Aug 28, 2025
Maintained: Buy
Price Target: $3.30
Current: $2.98
Upside: +10.74%
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $7.91
Upside: n/a
Feb 12, 2025
Maintained: Hold
Price Target: $3.80 → $3.95
Current: $5.24
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $208.96
Upside: n/a
Jun 24, 2024
Maintained: Buy
Price Target: $33.70
Current: $29.99
Upside: n/a
Jun 12, 2024
Maintained: Buy
Price Target: $310.00
Current: $128.07
Upside: n/a
May 22, 2024
Maintained: Buy
Price Target: $33.60 → $31.65
Current: $22.72
Upside: n/a
Apr 9, 2024
Maintained: Hold
Price Target: $25.38 → $24.14
Current: $33.64
Upside: n/a
Mar 22, 2024
Maintained: Hold
Price Target: $25.85 → $27.79
Current: $41.75
Upside: n/a
Mar 21, 2024
Maintained: Sell
Price Target: $276.00 → $256.00
Current: $122.50
Upside: n/a
Feb 28, 2024
Maintained: Sell
Price Target: $1.30
Current: $0.38
Upside: n/a
Feb 27, 2024
Maintained: Hold
Price Target: $8.15 → $7.35
Current: $7.66
Upside: n/a
Feb 26, 2024
Maintained: Buy
Price Target: $1.45 → $1.65
Current: $0.69
Upside: n/a
Jan 12, 2024
Maintained: Buy
Price Target: $46.90 → $45.69
Current: $22.61
Upside: n/a
Nov 28, 2023
Maintained: Hold
Price Target: $53.60 → $51.60
Current: $44.26
Upside: n/a
Aug 28, 2023
Maintained: Sell
Price Target: $2.70 → $2.75
Current: $2.09
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $15.45
Upside: n/a